<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="mobile-web-app-capable" content="yes" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no">
  <title>Report</title>
	<!-- CSS -->
	<link rel="stylesheet" href="http://appsforoffice.microsoft.com/fabric/1.0/fabric.min.css">
	<!--<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.0.11/css/all.css" integrity="sha384-p2jx59pefphTFIpeqCcISO9MdVfIm4pNnsL08A6v5vaQc4owkQqxMV8kg4Yvhaw/" crossorigin="anonymous">-->
	<link rel="stylesheet" href="assets/libs/font-awesome-4.5.0/css/font-awesome.min.css">
	<link rel="stylesheet" href="assets/libs/bootstrap-4.0.0-alpha.2/dist/css/bootstrap.min.css">
	<link rel="stylesheet" href="assets/css/app.css">
	<link rel="stylesheet" href="assets/css/report.css">

</head>
<body ng-app="plio">	
	
		<!-- CANVAS -->
	  <section>	 
		  <div class="container"> 
			  <h1>
				  <strong>Shift Bioscience Ltd</strong> <span class="text-muted">Business model canvas</span>
				  <button type="button" class="btn btn-primary pull-right">Download as PDF</button>
				</h1>
			  <div ng-include="'includes/canvas.html'"></div>
			  <div class="text-right margin-top-10 text-muted">
				  <i class="fa fa-creative-commons"></i>
				  Canvas by Strategyzer.com
			  </div>		  
		  </div>
	  </section>
	  <!-- end of CANVAS -->

	  
	  <!-- CHARTS -->
	  <section class="report-section">
		  <div class="container">
			  <h1><strong>Shift Bioscience Ltd</strong> <span class="text-muted">Canvas charts (1)</span></h1>
			  <hr>
			  <div class="row">
				  <div class="col-xs-4">
					  <h5 class="report-chart-heading"><strong>Customer segments</strong></h5>
					  <p class="report-chart-subheading text-muted">% of market</p>
	          <div class="report-chart-wrapper">
		          <i class="fa fa-smile-o"></i>
	            <canvas height="1200" width="1200" id="customerSegmentsChart"></canvas>
	          </div>
	          <div class="report-chart-legend" id="customerSegmentsChartLegend"></div>
				  </div>
				  <div class="col-xs-4">
					  <h5 class="report-chart-heading"><strong>Revenue streams</strong></h5>
					  <p class="report-chart-subheading text-muted">% of revenue</p>
	          <div class="report-chart-wrapper">
		          <i class="fa fa-usd"></i>
	            <canvas height="1200" width="1200" id="revenueStreamsChart"></canvas>
	          </div>
	          <div class="report-chart-legend" id="revenueStreamsChartLegend"></div>
				  </div>
				  <div class="col-xs-4">
					  <h5 class="text-center margin-bottom-5"><strong>Profit streams</strong></h5>
					  <p class="text-center text-muted">% of profit</p>
	          <div class="report-chart-wrapper">
		          <i class="fa fa-usd"></i>
	            <canvas height="1200" width="1200" id="profitStreamsChart"></canvas>
	          </div>
	          <div class="report-chart-legend" id="profitStreamsChartLegend"></div>
				  </div>
			  </div>
		  </div>
	  </section>
	  <!-- end of CHARTS -->
	  
	  
	  <!-- CHARTS -->
	  <section class="report-section">
		  <div class="container">
			  <h1><strong>Shift Bioscience Ltd</strong> <span class="text-muted">Canvas charts (2)</span></h1>
			  <hr>
			  <div class="row">
				  <div class="col-xs-4">
					  <h5 class="report-chart-heading"><strong>Key partners</strong></h5>
					  <p class="report-chart-subheading text-muted">criticality vs spend</p>
	          <div class="report-chart-wrapper">
	            <canvas height="1200" width="1200" id="keyPartnersChart"></canvas>
	          </div>
	          <div class="report-chart-legend" id="keyPartnersChartLegend"></div>
				  </div>
				  <div class="col-xs-4">
					  <h5 class="report-chart-heading"><strong>Cost structure</strong></h5>
					  <p class="report-chart-subheading text-muted">% of total costs</p>
	          <div class="report-chart-wrapper">
		          <i class="fa fa-tags"></i>
	            <canvas height="1200" width="1200" id="costStructureChart"></canvas>
	          </div>
	          <div class="report-chart-legend" id="costStructureChartLegend"></div>
				  </div>
			  </div>
		  </div>
	  </section>
	  <!-- end of CHARTS -->

    
		<!-- CUSTOMER INSIGHTS -->
  	<section class="report-section">
	  	<div class="container">
			  <h1>
				  <strong>Shift Bioscience Ltd</strong> <span class="text-muted">Customer insights</span>
				  <i class="fa fa-lg fa-smile-o pull-right"></i>
				</h1>
		  	<hr>
		  	<div class="row">
			  	<div class="col-xs-6">
					  <h6>Customer segment 1:</h6>
						<h5>Pharmaceutical firms</h5>
						<p class="report-linkage">
							<span>Matched to VP2 Novel drug molecule for age-related diseases</span>
						</p>
						<h6>Needs:</h6>
						<ul class="list-unstyled">
							<li>
								Candidate drug molecule for age-related diseases <span class="text-muted">(CN1)</span>
								<br><span class="text-muted">Matched to FE1 New drug molecule for AD</span>
							</li>
							<li>
								Maximum acquisition price of £10m <span class="text-muted">(CN2)</span>
								<br><span class="text-muted">Matched to FE2 Low upfront licensing fee </span>
							</li>
							<li>Proven safe in Phase I trial <span class="text-muted">(CN3)</span></li>
						</ul>
						<h6>Wants:</h6>
						<ul class="list-unstyled">
							<li>Efficacy shown in Phase II trial <span class="text-muted">(CW1)</span></li>
							<li>Global rights <span class="text-muted">(CW2)</span></li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-6">
					  <h6>Customer segment 2:</h6>
						<h5>Biotechnology firms</h5>
						<p class="report-linkage">
							<span>Matched to VP2 Novel drug molecule for age-related diseases</span>
						</p>
						<h6>Needs:</h6>
						<ul class="list-unstyled">
							<li>Candidate drug molecule for age-related diseases <span class="text-muted">(CN1)</span></li>
							<li>Maximum acquisition price of £5m <span class="text-muted">(CN4)</span></li>
							<li>Proven safe in Phase I trial <span class="text-muted">(CN3)</span></li>
						</ul>
						<h6>Wants:</h6>
						<ul class="list-unstyled">
							<li>Efficacy shown in Phase II trial <span class="text-muted">(CW1)</span></li>
							<li>Valuation-enhancing investor story <span class="text-muted">(CW3)</span></li>
							<li>Regional rights <span class="text-muted">(CW4)</span></li>
						</ul>		  	
			  	</div>
		  	</div>
		  	<hr>
		  	<div class="page-break"></div>
		  	<div class="row">
			  	<div class="col-xs-6">
					  <h6>Customer segment 3:</h6>
						<h5>Genome diagnostic firms</h5>
						<p class="report-linkage">
							<span>Matched to VP3 Novel mitochondrial diagnostic test (to use with drug or independently)</span>
						</p>
						<h6>Needs:</h6>
						<ul class="list-unstyled">
							<li>Candidate drug molecule for age-related diseases <span class="text-muted">(CN1)</span></li>
							<li>Maximum acquisition price of £1m <span class="text-muted">(CN5)</span></li>
							<li>Efficacy shown in Phase II trial <span class="text-muted">(CN6)</span></li>
						</ul>
						<h6>Wants:</h6>
						<ul class="list-unstyled">
							<li>Valuation-enhancing investor story <span class="text-muted">(CW3)</span></li>
							<li>Regional rights <span class="text-muted">(CW4)</span></li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-6">
					  <h6>Customer segment 4:</h6>
						<h5>Mitochondrial disease clinicians</h5>
						<p class="report-linkage">
							<span>Matched to VP1 Compassionate drug use (rare mito diseases)</span>
						</p>
						<h6>Needs:</h6>
						<ul class="list-unstyled">
							<li>New therapies for patients with incurable mitochondrial diseases <span class="text-muted">(CN7)</span></li>
							<li>Access to sufficient drug for patient trials <span class="text-muted">(CN8)</span></li>
							<li>Endorsement by reputable clinician or scientist <span class="text-muted">(CN9)</span></li>
						</ul>
						<h6>Wants:</h6>
						<ul class="list-unstyled">
							<li>Efficacy shown in Phase II trial <span class="text-muted">(CW1)</span></li>
							<li>Publication rights <span class="text-muted">(CW5)</span></li>
						</ul>		  	
			  	</div>
		  	</div>
	  	</div>
  	</section>
  	<!-- end of CUSTOMER INSIGHTS -->
  	
  	
  	
  	<!-- VALUE COMPONENTS -->
  	<section class="report-section">
	  	<div class="container">
			  <h1>
				  <strong>Shift Bioscience Ltd</strong> <span class="text-muted">Value components</span>
				  <i class="fa fa-lg fa-gift pull-right"></i>
				</h1>
		  	<hr>
		  	<div class="row">
			  	<div class="col-xs-6">
					  <h6>Value proposition 1:</h6>
						<h5>Compassionate drug use (rare mito diseases)</h5>
						<p class="report-linkage">
							<span>Matched to CS4 Mitochondrial disease clinicians</span>
						</p>
						<h6>Features:</h6>
						<ul class="list-unstyled">
							<li>
								Small molecule <span class="text-muted">(PF1)</span>
								<br><span class="text-muted">Matched to CN1 New drug molecule for AD</span>
							</li>
							<li>
								Low toxicity <span class="text-muted">(PF2)</span>
								<br><span class="text-muted">Matched to CN2 New drug molecule for AD with low toxicity</span>
							</li>
						</ul>
						<h6>Benefits:</h6>
						<ul class="list-unstyled">
							<li>Convenient for patient <span class="text-muted">(PB1)</span></li>
							<li>Few side effects <span class="text-muted">(PB2)</span></li>
						</ul>	  	
			  	</div>
			  	<div class="col-xs-6">
					  <h6>Value proposition 2:</h6>
						<h5>Novel drug therapy for age-related diseases</h5>
						<p class="report-linkage">
							<span>Matched to CS1 Pharmaceutical firms</span>
						</p>
						<h6>Features:</h6>
						<ul class="list-unstyled">
							<li>Small molecule <span class="text-muted">(PF1)</span></li>
							<li>Low toxicity <span class="text-muted">(PF2)</span></li>
							<li>Optimal formulation for ALS <span class="text-muted">(PF3)</span></li>
						</ul>
						<h6>Benefits:</h6>
						<ul class="list-unstyled">
							<li>Convenient for patient <span class="text-muted">(PB1)</span></li>
							<li>Few side effects <span class="text-muted">(PB2)</span></li>
						</ul>		  	
			  	</div>
			  	
		  	</div>
		  	<hr>
		  	<div class="page-break"></div>
		  	<div class="row">
			  	<div class="col-xs-6">
					  <h6>Value proposition 3:</h6>
						<h5>Novel mitochondrial diagnostic test (to use with drug or independently)</h5>
						<p class="report-linkage">
							<span>Matched to CS3 Diagnostic firms</span>
						</p>
						<h6>Features:</h6>
						<ul class="list-unstyled">
							<li>Easy-to-use consumer kit <span class="text-muted">(PF6)</span></li>
							<li>Test can be done in 10 mins <span class="text-muted">(PF7)</span></li>
							<li>Accurate <span class="text-muted">(PF8)</span></li>
						</ul>
						<h6>Benefits:</h6>
						<ul class="list-unstyled">
							<li>High return rates <span class="text-muted">(PB5)</span></li>
							<li>Trustworthy results <span class="text-muted">(PB6)</span></li>
						</ul>		  	
			  	</div>
			  	
		  	</div>
	  	</div>
  	</section>
  	<!-- end of VALUE COMPONENTS -->
  	
  	
  	
  	<!-- PRODUCT/MARKET FIT 
  	<section class="report-section">
	  	<div class="container">
			  <h1><strong>Shift Bioscience Ltd</strong> <span class="text-muted">Product/market fit</span></h1>
		  	<hr>
		  	<div class="row">
			  	<div class="col-xs-6">
					  <h6>Value proposition:</h6>
						<h5>Novel drug therapy for age-related diseases <i class="fa fa-arrows-alt-h product-market-fit-arrows"></i></h5>
						<p class="report-linkage">
							<i class="fa fa-long-arrow-right"></i>
							<span>Linked to customer segment: Pharmaceutical firms</span>
						</p>
						<h6>Features:</h6>
						<ul class="list-unstyled">
							<li>
								Small molecule <span class="text-muted">(PF1)</span>
								<p class="report-linkage">
									<i class="fa fa-long-arrow-right"></i>
									<span>matched to Candidate drug molecule for age-related diseases (CN1)</span>
								</p>	
							</li>
							<li>
								Low toxicity <span class="text-muted">(PF2)</span>
								<p class="report-linkage">
									<i class="fa fa-long-arrow-right"></i>
									<span>matched to Maximum acquisition price of £10m (CN2)</span>
								</p>
								<p class="report-linkage">
									<i class="fa fa-long-arrow-right"></i>
									<span>matched to Efficacy shown in Phase II trial (CW1)</span>
								</p>	
							</li>
							<li>
								Optimal formulation for ALS <span class="text-muted">(PF3)</span>
								<p class="report-linkage">
									<i class="fa fa-long-arrow-right"></i>
									<span>matched to Global rights (CW2)</span>
								</p>	
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-6">
					  <h6>Customer segment:</h6>
						<h5>Pharmaceutical firms</h5>
						<h6>Benefits:</h6>
						<ul class="list-unstyled">
							<li>
								Convenient for patient <span class="text-muted">(PB1)</span>
								<p class="report-linkage">
									<i class="fa fa-long-arrow-right"></i>
									<span>matched to Valuation-enhancing investor story (CW3)</span>
								</p>							
							</li>
							<li>
								Few side effects <span class="text-muted">(PB2)</span>
								<p class="report-linkage">
									<i class="fa fa-long-arrow-right"></i>
									<span>matched to Maximum acquisition price of £1m (CN5)</span>
								</p>	
							</li>
						</ul>		  	
			  	</div>
		  	</div>
	  	</div>
  	</section>
  	<!-- end of PRODUCT/MARKET FIT -->
  	
  	
  	
  	<!-- OPERATIONAL ELEMENTS -->
  	<section class="report-section">
	  	<div class="container">
			  <h1>
				  <strong>Shift Bioscience Ltd</strong> <span class="text-muted">Operational elements</span>
				  <i class="fa fa-industry pull-right"></i>
				</h1>
		  	<hr>
		  	<h5>Customer segments</h5>
		  	<div class="row">
			  	<div class="col-xs-3">
					  <h6>Key goals:</h6>
						<ul class="list-unstyled">
							<li>
								KG1. Finish UI design
							</li>
							<li>
								KG2. Get new website live
							</li>
							<li>
								KG3. Close New York office
							</li>
							<li>
								KG4. Launch Product X
							</li>
							<li>
								KG5. Evaluate business case for Y
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>Standards:</h6>
						<ul class="list-unstyled">
							<li>
								SOP1. Client feedback
							</li>
							<li>
								SOP2. Inquiry handling
							</li>
							<li>
								SOP3. Client onboarding
							</li>
							<li>
								SOP4. Identification of needs
							</li>
							<li>
								SOP5. Verification of ID
							</li>
							<li>
								SOP6. Due diligence
							</li>
							<li>
								SOP7. Client deal execution
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>Risks:</h6>
						<ul class="list-unstyled">
							<li>
								RK1. Industrial accidents
							</li>
							<li>
								RK2. Strike or stoppage
							</li>
							<li>
								RK3. Explosion of binder
							</li>
							<li>
								RK4. Spillage of solvent
							</li>
							<li>
								RK5. Severe weather
							</li>
							<li>
								RK6. Transport accident
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>NCs &amp; gains:</h6>
						<ul class="list-unstyled">
							<li>
								NC1. Data file lost
							</li>
							<li>
								NC2. Inquiry not recorded
							</li>
							<li>
								NC3. Brackets getting corroded
							</li>
							<li>
								NC4. Mouldings are wrong color
							</li>
							<li>
								NC5. Extrusion failed in service
							</li>
							<li>
								NC6. Supplier X delivered late
							</li>
							<li>
								NC7. Supplier Y failed to replace item
							</li>
						</ul>		  	
			  	</div>
			  	
		  	</div>
		  	<hr>
		  	
		  	<h5>Key partners</h5>
		  	<div class="row">
			  	<div class="col-xs-3">
					  <h6>Key goals:</h6>
						<ul class="list-unstyled">
							<li>
								KG1. Finish UI design
							</li>
							<li>
								KG2. Get new website live
							</li>
							<li>
								KG5. Evaluate business case for Y
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>Standards:</h6>
						<ul class="list-unstyled">
							<li>
								SOP1. Client feedback
							</li>
							<li>
								SOP2. Inquiry handling
							</li>
							<li>
								SOP3. Client onboarding
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>Risks:</h6>
						<ul class="list-unstyled">
							<li>
								RK5. Severe weather
							</li>
							<li>
								RK6. Transport accident
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>NCs &amp; gains:</h6>
						<ul class="list-unstyled">
							<li>
								NC6. Supplier X delivered late
							</li>
							<li>
								NC7. Supplier Y failed to replace item
							</li>
						</ul>		  	
			  	</div>
			  	
		  	</div>
		  	<hr>
		  	<h5>Key activities</h5>
		  	<div class="row">
			  	<div class="col-xs-3">
					  <h6>Key goals:</h6>
						<ul class="list-unstyled">
							<li>
								KG1. Finish UI design
							</li>
							<li>
								KG2. Get new website live
							</li>
							<li>
								KG3. Close New York office
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>Standards:</h6>
						<ul class="list-unstyled">
							<li>
								SOP1. Verification of ID
							</li>
							<li>
								SOP2. Due diligence
							</li>
							<li>
								SOP3. Client deal execution
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>Risks:</h6>
						<ul class="list-unstyled">
							<li>
								RK1. Industrial accidents
							</li>
							<li>
								RK2. Strike or stoppage
							</li>
							<li>
								RK3. Explosion of binder
							</li>
							<li>
								RK4. Spillage of solvent
							</li>
						</ul>		  	
			  	</div>
			  	<div class="col-xs-3">
					  <h6>NCs &amp; gains:</h6>
						<ul class="list-unstyled">
							<li>
								NC1. Data file lost
							</li>
							<li>
								NC2. Inquiry not recorded
							</li>
							<li>
								NC3. Brackets getting corroded
							</li>
							<li>
								NC4. Mouldings are wrong color
							</li>
						</ul>		  	
			  	</div>
			  	
		  	</div>
	  	</div>
  	</section>
  	<!-- end of OPERATIONAL ELEMENTS -->



	</div>
	


	<!-- JS -->
	<script src="assets/libs/angular/angular.min.js"></script>
	<script src="assets/libs/jquery/dist/jquery.min.js"></script>
	<script src="https://cdnjs.cloudflare.com/ajax/libs/Chart.js/2.7.2/Chart.min.js"></script>
	<script src="assets/js/report.js"></script>

</body>
</html>